Avantgen

AvantGen is a premier partner in advancing antibody drugs, specializing in the discovery and optimization of novel antibody drugs. With a dedicated and flexible team, they provide a platform that has resulted in success for multiple projects, including difficult targets and novel reagents. Their innovative approach and collaborative mindset have contributed to the success of various programs, making them a trusted partner in the field of antibody discovery.

AvantGen's proprietary and robust yeast display system, coupled with their Germliner Library Collection, offers three fully human platforms with over 100 billion antibody clones. These platforms boast highly favorable properties such as high affinity, specificity, thermostability, expression level, and low immunogenicity. Additionally, AvantGen leverages their expertise in library design and engineered platforms to optimize lead candidates, improving affinity by 10- to 100-fold. For those interested in nonhuman reagent or diagnostic antibodies, AvantGen also offers a rabbit immune system-based platform that provides monoclonal antibodies with superior affinity and specificity.

Generated from the website